Dr. Mark S. Anderson is an endocrinologist who cares for adult patients with type 1 diabetes or other autoimmune endocrine diseases.
In his research, Anderson focuses on the genetic and molecular underpinnings of such autoimmune diseases as type 1 diabetes and Hashimoto's disease. His lab group has a particular interest in how T cells – white blood cells that mature in the thymus gland and play an important role in immune response – can provoke autoimmunity.
After earning a doctorate in immunology from the Pritzker School of Medicine at the University of Chicago, Anderson completed his medical degree there. He completed a residency in internal medicine at University of Minnesota Health and a fellowship in endocrinology at Massachusetts General Hospital.
Anderson is a member of the American Diabetes Association, American Association of Immunologists, Association for Research in Vision and Ophthalmology, Endocrine Society, American Society for Clinical Investigation, Federation of Clinical Immunology Societies and Association of American Physicians. He serves on the advisory committee for Pathway to Stop Diabetes, a program to support diabetes researchers initiated by the American Diabetes Association.
Pritzker School of Medicine, PhD, Immunology, 1992
Pritzker School of Medicine, 1994
University of Minnesota Health, Internal Medicine, 1998
Massachusetts General Hospital, Adult Clinical Endocrinology, 2001
Endocrinology Diabetes & Metab, American Board of Internal Medicine
Professor
